Use of pyroglutamyl-glutamyl-prolyl amide (EEP) for neurological and neurobehavioral disorders

   
   

A tri-peptide drug for treatment of neurological and neurobehavioral disorders of a mammal, such drug being derived from the following formula: pGlu-X-Pro-NH.sub.2, wherein the internal amino acid (X) is a non-histadine amino acid. Methods of treatment of neurological disorders using the tri-peptide, including as an adjunct, synergist or stand-alone therapy, in oral, parenteral, intranasal, transcutaneous, or rectal forms.

Una droga del tri-peptide para el tratamiento de desórdenes neurológicos y neurobehavioral de un mamífero, tal droga que es derivada del fórmula siguiente: pGlu-X-Pro-NH.sub.2, en donde el aminoácido interno (x) es un aminoácido del non-histadine. Métodos de tratamiento de desórdenes neurológicos usando el tri-peptide, incluyendo como un adjunto, un synergist o terapia independiente, en formas orales, parenteral, intranasales, transcutáneas, o rectales.

 
Web www.patentalert.com

< Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes

< Methods for enhancing thrombolysis in a mammal

> Preparation capable of releasing drug at target site in intestine

> Plasmid originated from bifidobacterium, recombinant expression vector using the plasmid and transformation method

~ 00160